Urinary L-erythro-β-hydroxyasparagine—a novel serine racemase inhibitor and substrate of the Zn2+-dependent D-serine dehydratase

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

In the present study, we identified L-erythro-β-hydroxyasparagine (L-β-EHAsn) found abundantly in human urine, as a novel substrate of Zn2+-dependent D-serine dehydratase (DSD). L-β-EHAsn is an atypical amino acid present in large amounts in urine but rarely detected in serum or most organs/tissues examined. Quantitative analyses of urinary L-β-EHAsn in young healthy volunteers revealed significant correlation between urinary L-β-EHAsn concentration and creatinine level. Further, for in-depth analyses of L-β-EHAsn, we developed a simple three-step synthetic method using trans-epoxysuccinic acid as the starting substance. In addition, our research revealed a strong inhibitory effect of L-β-EHAsn on mammalian serine racemase, responsible for producing D-serine, a co-agonist of the N-methyl-D-aspartate (NMDA) receptor involved in glutamatergic neurotransmission.

Cite

CITATION STYLE

APA

Ito, T., Tono, M., Kitaura, Y., Hemmi, H., & Yoshimura, T. (2021). Urinary L-erythro-β-hydroxyasparagine—a novel serine racemase inhibitor and substrate of the Zn2+-dependent D-serine dehydratase. Bioscience Reports, 41(4). https://doi.org/10.1042/BSR20210260

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free